European Archives - Page 582 of 1349 - European Medical Journal

This site is intended for healthcare professionals

Continue
9 Mins
23 Nov 2023

Review of the European Academy of Dermatology and Venereology (EADV) Congress 2023

BERLIN, Germany, was the setting for the 2023 European Academy of Dermatology and Venereology (EADV) Congress. With over 15,500 attendees…
November 2023

EMJ Dermatology 11.1 2023

Dive into the latest issue of EMJ Dermatology, for an array of peer-reviewed articles, exclusive interviews with leading experts, and an…
7 Mins
23 Nov 2023

Bimekizumab 3-Year Efficacy in Patients with Moderate-to-Severe Plaque Psoriasis: Response Maintenance, Re-treatment, and Effect on High-Impact Areas

Psoriasis symptoms can be not only uncomfortable, irritating, and painful, but can also impact several aspects of a patients’ daily life…
1 Mins
23 Nov 2023

Efficacy and Improvement of Qualify of Life in Patients Treated with Brodalumab in Real Clinical Practice: A Case Series of 31 Patients

Brodalumab, a fully human recombinant monoclonal antibody of the IgG2 type, binds strongly to IL-17 receptor A,3 effectively inhibiting…
4 Mins
23 Nov 2023

Atopic Dermatitis

Eyerich began his presentation by explaining that although the four primary factors in the pathogenesis of atopic dermatitis…
1 Mins
23 Nov 2023

Clinical Presentation and Diagnostic Features of Onychomatricoma: A Case Report

Onychomatricoma is an infrequent, benign fibroepithelial tumour originating from the nail matrix. While the exact cause of onychomatricoma…
8 Mins
23 Nov 2023

Secukinumab for Patients with Moderate-to-Severe Hidradenitis Suppurativa: Post Hoc Analyses of Efficacy Endpoints, Draining Tunnels, Skin Pain, and Work Productivity

Due to the clinical heterogenicity of HS, assessment of disease severity is complex, and over 20 different outcome measures have…
4 Mins
23 Nov 2023

Scarring Alopecia: Cutting-Edge Approaches

Jerry Shapiro, New York University (NYU) Langone Health, USA, presented on evaluating and diagnosing scarring alopecia…
2 Mins
23 Nov 2023

Efficacy and Safety of Upadacitinib in a Phase II Randomised, Double-Blind, Dose-Ranging Study of Adults with Extensive Non-segmental Vitiligo

Vitiligo is an autoimmune skin disorder that causes depigmentation of the skin and/or leukotrichia of the hair, resulting from the…
1 Mins
23 Nov 2023

Lichen Sclerosus in Prepubertal Males: Breaking the Paradigm

Lichen sclerosus (LS) is a chronic inflammatory condition primarily affecting the genital area, characterised by hypopigmented skin…
We’ve noticed you’re accessing
from North/South America.